Trifluoroacetic acid → HCID 59924650, compound
Reaction equation
[C:1]1([C@@H:7]([NH:9][C:10]2[N:15]=[C:14]([N:16]3[C:20]4[CH:21]=[CH:22][C:23]([O:25][CH2:26][CH:27]5[CH2:31][CH2:30][CH2:29][N:28]5C(OCC5C=CC=CC=5)=O)=[CH:24][C:19]=4[N:18]=[CH:17]3)[CH:13]=[CH:12][N:11]=2)[CH3:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.FC(F)(F)C(O)=O>CO.[OH-].[OH-].[Pd+2]>[C:1]1([C@@H:7]([NH:9][C:10]2[N:15]=[C:14]([N:16]3[C:20]4[CH:21]=[CH:22][C:23]([O:25][CH2:26][CH:27]5[CH2:31][CH2:30][CH2:29][NH:28]5)=[CH:24][C:19]=4[N:18]=[CH:17]3)[CH:13]=[CH:12][N:11]=2)[CH3:8])[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
2-[(S)-1-Phenylethylamino]-4-[5-((N-benzyloxycarbonyl-pyrrolidin-2-yl)methoxy)benzimidazol-1-yl]pyrimidine (11 mg) was dissolved in methanol (1.0 mL) and catalytic Pd(OH)2 and trifluoroacetic acid were added and the resulting suspension was stirred under hydrogen atmosphere for 15 hours. Filtration and evaporation of solvent gave N-[(1S)-1-phenylethyl]-4-[5-(2-pyrrolidinylmethoxy)-1H-benzimidazol-1-yl]-2-pyrimidinamine (7.0 mg). Mass spectrum (ESI) 415.5 (M+1).
Workup
- filtrationFiltration and evaporation of solvent
Sources & evidence
- ORD record
- ord-05d5be6a5cc64075a1bd0ed7b18a7c9d
- Source dataset
- uspto-grants-2002_12
- Patent number
- US06498165B1
Reaction notes
Loading…